Federated Hermes, Inc. Rocket Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$15.07 - $24.05 $64,559 - $103,030	-4,284 Reduced 45.19%	5,197 $106,000
Q2 2023 Aug 14, 2023	SELL	$16.59 - $23.6 $28,219 - $40,143	-1,701 Reduced 15.21%	9,481 $188,000
Q1 2023 May 08, 2023	BUY	$15.79 - $22.6 $32,022 - $45,832	2,028 Added 22.15%	11,182 $191,000
Q4 2022 Feb 13, 2023	BUY	$15.5 - $22.76 $36,161 - $53,099	2,333 Added 34.2%	9,154 $179,000
Q3 2022 Nov 14, 2022	SELL	$12.37 - $18.41 $3.42 Million - $5.09 Million	-276,303 Reduced 97.59%	6,821 $109,000
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $1.15 Million - $2.41 Million	-144,727 Reduced 33.83%	283,124 $3.9 Million
Q1 2022 May 13, 2022	BUY	$13.16 - $23.68 $5.63 Million - $10.1 Million	427,851 New	427,851 $6.79 Million
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $368,010 - $441,220	-9,338 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$43.34 - $65.91 $294,321 - $447,594	-6,791 Reduced 42.1%	9,338 $414,000
Q4 2020 Feb 12, 2021	SELL	$23.3 - $59.57 $4.14 Million - $10.6 Million	-177,497 Reduced 91.67%	16,129 $885,000
Q3 2020 Nov 12, 2020	BUY	$20.5 - $28.59 $3.97 Million - $5.54 Million	193,626 New	193,626 $4.43 Million
Q2 2020 Aug 13, 2020	SELL	$13.32 - $22.61 $2.27 Million - $3.86 Million	-170,545 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$9.71 - $25.11 $1.25 Million - $3.23 Million	128,734 Added 307.9%	170,545 $2.38 Million
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $462,847 - $1.01 Million	41,811 New	41,811 $952,000
Q1 2019 May 10, 2019	SELL	$13.45 - $19.01 $5.43 Million - $7.67 Million	-403,452 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$11.21 - $23.53 $1.79 Million - $3.77 Million	-160,022 Reduced 28.4%	403,452 $5.98 Million
Q3 2018 Nov 13, 2018	BUY	$18.5 - $25.49 $10.4 Million - $14.4 Million	563,474 New	563,474 $13.9 Million

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$239 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$152 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$83.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$74.8 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$60.7 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.02B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account